SCHEMBL8953076

SCHEMBL8953076

Cc1cc(F)ccc1-c1cc(-c2ccccc2)nc(C(C)C)c1CCP(=O)(O)CC(O)CC(=O)O

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.42
CTSA P10619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8953067 1.00 HMGCR (0.42) HMGCRCTSA
SCHEMBL8953077 0.90 HMGCR (0.50) HMGCR
SCHEMBL8952739 0.90 HMGCR (0.50) HMGCR
SCHEMBL8952944 0.89 HMGCR (0.42) HMGCR
SCHEMBL8952977 0.85 HMGCR (0.45) HMGCR
SCHEMBL8952706 0.82
SCHEMBL8952711 0.82
SCHEMBL8953165 0.81
SCHEMBL8953141 0.81
SCHEMBL8953159 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5506219-A ANTICHOLESTEROL AND ANTILIPEMIC AGENTS E. R. SQUIBB & SONS, INC. (US) 1996-04-09 US disclosed
EP-0444533-A2 Quinoline and pyridine anchors for HMG-CoA reductase inhibitors E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed